These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24567352)

  • 1. Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus.
    Savu O; Serafinceanu C; Grajdeanu IV; Iosif L; Gaman L; Stoian I
    J Int Med Res; 2014 Apr; 42(2):523-9. PubMed ID: 24567352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxidation status and antioxidant capacity in psoriatic children.
    Bacchetti T; Simonetti O; Ricotti F; Offidani A; Ferretti G
    Arch Dermatol Res; 2020 Jan; 312(1):33-39. PubMed ID: 31531730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
    Zhou M; Liu XH; Liu QQ; Chen M; Bai H; Guan LB; Fan P
    J Diabetes Res; 2020; 2020():3483427. PubMed ID: 32090118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus.
    Zhou M; Liu XH; Liu QQ; Chen M; Bai H; Jiang CY; Guan LB; Fan P
    Pediatr Res; 2021 Apr; 89(5):1192-1199. PubMed ID: 32570269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus.
    Craciun EC; Leucuta DC; Rusu RL; David BA; Cret V; Dronca E
    Acta Biochim Pol; 2016; 63(3):511-5. PubMed ID: 27337219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
    Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
    Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases)].
    Fekih O; Triki S; Hellara I; Neffati F; Chouchane S; Neji Gueddiche M; Fadhel Najjar M
    Presse Med; 2015 May; 44(5):e185-90. PubMed ID: 25769648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes of oxidative stress and PON1 lactonase activity and status in older pregnant women undergoing assisted reproductive technology: a prospective nested case-control study.
    Jiang C; Chen M; Wu Y; Bai H; Liu X; Fan P
    Reprod Biol Endocrinol; 2023 Oct; 21(1):97. PubMed ID: 37885002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood.
    Gugliucci A; Numaguchi M; Caccavello R; Kimura S
    Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
    Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM
    Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Lipoic Acid on Serum Paraoxonase-1 and Paraoxonase-3 Protein Levels and Activities in Diabetic Rats.
    Ozgun E; Ozgun GS; Gokmen SS; Eskıocak S; Sut N; Akıncı M; Goncu E; Cakır E
    Exp Clin Endocrinol Diabetes; 2019 Jun; 127(6):377-384. PubMed ID: 26849669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase 1 activities and genetic variation in childhood obesity.
    Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
    Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
    Variji A; Shokri Y; Fallahpour S; Zargari M; Bagheri B; Abediankenari S; Alizadeh A; Mahrooz A
    Atherosclerosis; 2019 Jan; 280():7-13. PubMed ID: 30448568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome.
    Zhang Y; Liu H; He J; Xu K; Bai H; Wang Y; Zhang F; Zhang J; Cheng L; Fan P
    Eur J Endocrinol; 2015 Apr; 172(4):391-402. PubMed ID: 25575948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
    Zsíros N; Koncsos P; Lőrincz H; Seres I; Katkó M; Szentpéteri A; Varga VE; Fülöp P; Paragh G; Harangi M
    Clin Biochem; 2016 Aug; 49(12):862-7. PubMed ID: 27129797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
    Flekac M; Skrha J; Žídková K; Lacinová Z; Hilgertová J
    Physiol Res; 2008; 57(5):717-726. PubMed ID: 17949258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia.
    Szentpéteri A; Zsíros N; Varga VE; Lőrincz H; Katkó M; Seres I; Fülöp P; Paragh G; Harangi M
    Vasa; 2017 Aug; 46(5):370-376. PubMed ID: 28602123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased PON lactonase activity in morbidly obese patients is associated with impaired lipid profile.
    Alaminos-Castillo MÁ; Ho-Plagaro A; García-Serrano S; Santiago-Fernandez C; Rodríguez-Pacheco F; Garrido-Sanchez L; Rodriguez C; Valdes S; Gonzalo M; Moreno-Ruiz FJ; Rodríguez-Cañete A; Montiel-Casado C; Garcia-Fuentes E
    Int J Clin Pract; 2019 Jun; 73(6):e13315. PubMed ID: 30681756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.